Executive Committee: MBX Biosciences, Inc.

Manager
Positions heldSince
Peter Hawryluk

Peter Hawryluk

57 year

Chief Executive Officer 2019-12-31
Founder 2018-07-31
President 2019-12-31
Jim DeNike

Jim DeNike

Investor Relations Contact -
Michelle Graham

Michelle Graham

59 year

Human Resources Officer 2023-09-30
Stewart Hallett

Stewart Hallett

Chief Tech/Sci/R&D Officer 2023-12-31
Rick Bartram

Rick Bartram

45 year

Director of Finance/CFO 2022-03-31
Salomon Azoulay

Salomon Azoulay

69 year

Chief Tech/Sci/R&D Officer 2024-05-31

Composition of the Board of Directors: MBX Biosciences, Inc.

Director
CommitteesSince
Steven Hoerter

Steven Hoerter

55 year

Audit Committee 2025-11-05
Compensation Committee
Compensation Committee Chair 2025-06-17
Organization Committee Chair 2025-06-17
Ed Mathers Mathers

Ed Mathers Mathers

66 year

Compensation Committee 2024-10-03
Audit Committee 2025-10-30
Governance Committee Chair 2020-02-29
Nominating Committee Chair 2020-02-29
Governance Committee 2020-06-30
Nominating Committee 2020-06-30
Patrick Heron

Patrick Heron

55 year

Executive Committee
Compensation Committee
Governance Committee 2020-06-30
Nominating Committee 2020-06-30
Compensation Committee Chair 2020-06-30
Laurie Stelzer

Laurie Stelzer

58 year

Compensation Committee 2024-11-07
Audit Committee Chair 2026-01-19
Governance Committee 2023-11-26
Nominating Committee 2023-11-26
Ora Pescovitz

Ora Pescovitz

69 year

Executive Committee 2013-03-26
Governance Committee Chair 2022-04-04
Nominating Committee Chair 2022-04-04
Tiba Aynechi

Tiba Aynechi

51 year

Audit Committee Chair 2025-10-30
Steven Ryder

Steven Ryder

75 year

Director/Board Member 2023-12-31
Independent Dir/Board Member 2023-12-31
Peter Hawryluk

Peter Hawryluk

57 year

Director/Board Member

Former Officers and Directors: MBX Biosciences, Inc.

Insider
Positions held
SinceUntil
James Cornelius
James Cornelius
Director/Board Member 2020-08-31 2025-10-30
Independent Dir/Board Member 2020-08-31 2025-10-30
Carl Gordon
Carl Gordon
Director/Board Member 2020-06-30 2025-06-04
Independent Dir/Board Member 2020-06-30 2025-06-04
Steven Prestrelski
Steven Prestrelski
Chief Tech/Sci/R&D Officer 2023-06-30 2025-02-28
Kirk Ways
Kirk Ways
Chief Tech/Sci/R&D Officer 2023-10-31 2024-06-30
Timothy Knickerbocker
Timothy Knickerbocker
Chief Operating Officer 2020-07-31 2022-12-30
Richard DiMarchi
Richard DiMarchi
Director/Board Member 2018-07-31 -
Chief Tech/Sci/R&D Officer 2018-07-31 -
Founder 2018-07-31 -

Age distribution of managers

Parity Men Women

Male12
Female3

Of which Executive Committee

Male5
Female1

Of which Directors

Male7
Female1
Logo MBX Biosciences, Inc.
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.
Employees
63